| Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447, 2020 | 946 | 2020 |
| Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 181 (1), 41-51, 2021 | 510 | 2021 |
| AKI treated with renal replacement therapy in critically ill patients with COVID-19 S Gupta, SG Coca, L Chan, ML Melamed, SK Brenner, SS Hayek, ... Journal of the American Society of Nephrology 32 (1), 161-176, 2021 | 304 | 2021 |
| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 246 | 2021 |
| In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study SS Hayek, SK Brenner, TU Azam, HR Shadid, E Anderson, H Berlin, ... bmj 371, 2020 | 150 | 2020 |
| Soluble urokinase receptor (SuPAR) in COVID-19–related AKI TU Azam, HR Shadid, P Blakely, P O’Hayer, H Berlin, M Pan, P Zhao, ... Journal of the American Society of Nephrology 31 (11), 2725-2735, 2020 | 131 | 2020 |
| Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States MZ Molnar, A Bhalla, A Azhar, M Tsujita, M Talwar, V Balaraman, A Sodhi, ... American Journal of Transplantation 20 (11), 3061-3071, 2020 | 113 | 2020 |
| ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance HD Jacob J. Orme, Khalid A. Jazieh, Tiancheng Xie, Susan Harrington, Xin Liu ... OncoImmunology 9 (1), 2020 | 87 | 2020 |
| Chimeric antigen receptor T-cell therapy–associated cardiomyopathy in patients with refractory or relapsed non-Hodgkin lymphoma S Ganatra, R Redd, SS Hayek, R Parikh, T Azam, GA Yanik, L Spendley, ... Circulation 142 (17), 1687-1690, 2020 | 76 | 2020 |
| Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19 A Vasbinder, E Anderson, H Shadid, H Berlin, M Pan, TU Azam, I Khaleel, ... Diabetes Care 45 (3), 692-700, 2022 | 51 | 2022 |
| Representation of minorities and elderly patients in multiple myeloma clinical trials N Duma, T Azam, IB Riaz, M Gonzalez‐Velez, S Ailawadhi, R Go The Oncologist 23 (9), 1076-1078, 2018 | 43 | 2018 |
| Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials N Duma, SM Kothadia, TU Azam, S Yadav, J Paludo, J Vera Aguilera, ... The oncologist 24 (1), 96-102, 2019 | 40 | 2019 |
| Kidney recovery and death in critically ill patients with COVID-19–associated acute kidney injury treated with dialysis: the STOP-COVID cohort study CM Hsu, S Gupta, H Tighiouart, N Goyal, AJ Faugno, A Tariq, ... American journal of kidney diseases 79 (3), 404-416. e1, 2022 | 34 | 2022 |
| Identification of distinct clinical subphenotypes in critically ill patients with COVID-19 CR Vasquez, S Gupta, TA Miano, M Roche, J Hsu, W Yang, DN Holena, ... Chest 160 (3), 929-943, 2021 | 32 | 2021 |
| Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor–induced myocarditis A Vasbinder, YA Chen, A Procureur, A Gradone, TU Azam, D Perry, ... Cardio Oncology 4 (5), 689-700, 2022 | 22 | 2022 |
| Permissive cardiotoxicity: the clinical crucible of cardio-oncology C Porter, TU Azam, D Mohananey, R Kumar, J Chu, D Lenihan, S Dent, ... Cardio Oncology 4 (3), 302-312, 2022 | 21 | 2022 |
| Angiotensin‐converting enzyme inhibitors, angiotensin II receptor blockers, and outcomes in patients hospitalized for COVID‐19 M Pan, A Vasbinder, E Anderson, T Catalan, HR Shadid, H Berlin, ... Journal of the American Heart Association 10 (24), e023535, 2021 | 19 | 2021 |
| Relationship between preexisting cardiovascular disease and death and cardiovascular outcomes in critically ill patients with COVID-19 A Vasbinder, C Meloche, TU Azam, E Anderson, T Catalan, H Shadid, ... Circulation: Cardiovascular quality and outcomes 15 (10), e008942, 2022 | 16 | 2022 |
| Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID‐19 in the US AN Friedman, J Guirguis, R Kapoor, S Gupta, DE Leaf, LR Timsina, ... Obesity 29 (10), 1719-1730, 2021 | 15 | 2021 |
| Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States JL Jezmir, M Bharadwaj, A Chaitoff, B Diephuis, CP Crowley, SP Kishore, ... Cell Reports Medicine 2 (9), 2021 | 14 | 2021 |
Salim S. HayekUniversity of MichiganVerified email at med.umich.edu
